BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990
24 results:

  • 1. [Susceptibility study on the germline rare variants of bromodomain and extraterminal domain protein family-encoding genes and patients with cancer living in some regions of China].
    Huang Y; Li JH; Wang X; Zou Y; Huang WF; Liu C; Zhang H
    Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(42):3374-3381. PubMed ID: 36372767
    [No Abstract]    [Full Text] [Related]  

  • 2. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
    Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
    Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Strongly increased risk of gastric and duodenal ulcers among new users of low-dose aspirin: results from two large cohorts with new-user design.
    Nguyen TNM; Sha S; Chen LJ; Holleczek B; Brenner H; Schöttker B
    Aliment Pharmacol Ther; 2022 Jul; 56(2):251-262. PubMed ID: 35621052
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted silencing of mycl1 by RNA interference inhibits migration and invasion of MGC-803 gastric cancer cells.
    Qin P; Wang H; Zhang F; Huang Y; Chen S
    Cell Biochem Funct; 2019 Jun; 37(4):266-272. PubMed ID: 31025404
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pretreatment predictive value of blood neutrophil/lymphocyte ratio in R0 gastric cancer resectability.
    Borda A; Vila J; Fernández-Urién I; Zozaya JM; Guerra A; Borda F
    Gastroenterol Hepatol; 2017 Jan; 40(1):1-9. PubMed ID: 27142343
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. gastric cancer stem cells: evidence, potential markers, and clinical implications.
    Brungs D; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
    J Gastroenterol; 2016 Apr; 51(4):313-26. PubMed ID: 26428661
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression and prognostic value of mycl1 in gastric cancer.
    Chen S; Tang J; Huang L; Lin J
    Biochem Biophys Res Commun; 2015 Jan; 456(4):879-83. PubMed ID: 25528583
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnostic value of fecal calprotectin as a screening biomarker for gastrointestinal malignancies.
    Khoshbaten M; Pishahang P; Nouri M; Lashkari A; Alizadeh M; Rostami-Nejad M
    Asian Pac J Cancer Prev; 2014; 15(4):1667-70. PubMed ID: 24641386
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association of polymorphisms and haplotype in the region of TRIT1, mycl1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population.
    Chen S; Zheng Z; Tang J; Lin X; Wang X; Lin J
    Carcinogenesis; 2013 May; 34(5):1018-24. PubMed ID: 23349019
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association of a mycl1 single nucleotide polymorphism, rs3134613, with susceptibility to diffuse-type gastric cancer and with differentiation of gastric cancer in a southeast Chinese population.
    Chen SQ; Lin XD; Zhu JW; Tang Y; Lin JY
    DNA Cell Biol; 2010 Dec; 29(12):739-43. PubMed ID: 20874233
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis.
    Gao L; Nieters A; Brenner H
    Eur J Hum Genet; 2009 Dec; 17(12):1658-67. PubMed ID: 19536170
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial.
    Rodriguez RF; Bravo LE; Castro F; Montoya O; Castillo JM; Castillo MP; Daza P; Restrepo JM; Rodriguez MF
    J Palliat Med; 2007 Feb; 10(1):56-60. PubMed ID: 17298254
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population.
    Liu F; Pan K; Zhang X; Zhang Y; Zhang L; Ma J; Dong C; Shen L; Li J; Deng D; Lin D; You W
    Gastroenterology; 2006 Jun; 130(7):1975-84. PubMed ID: 16762620
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer.
    Nan HM; Song YJ; Yun HY; Park JS; Kim H
    World J Gastroenterol; 2005 Jul; 11(25):3834-41. PubMed ID: 15991278
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer.
    Isbir T; Yaylim I; Arikan S; Kaytan E; Karşidağ T; Bayrak S; Camlica H
    Cancer Detect Prev; 2002; 26(6):454-7. PubMed ID: 12507230
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. EcoRI polymorphism of the L-myc gene in gastric cancer patients.
    Dlugosz A; Adler G; Ciechanowicz A; Jaroszewicz-Heigelmann H; Starzynska T
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1231-5. PubMed ID: 12439118
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Rapid assessment of replication error phenotype in gastric cancer.
    Buonsanti G; Presciuttini S; Radice P; Pierotti MA; Bertario L; Ranzani GN
    Diagn Mol Pathol; 1998 Jun; 7(3):168-73. PubMed ID: 9836073
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
    Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
    Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Helicobacter pylori infection and genetic polymorphisms for cancer-related genes in gastric carcinogenesis.
    Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
    Biomed Pharmacother; 1997; 51(4):145-9. PubMed ID: 9207980
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.
    Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
    Cancer; 1996 Apr; 77(8 Suppl):1654-61. PubMed ID: 8608558
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.